All In MedTech

FDA Clearance Tracker · P080012-S019

PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 4, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080012-S019
Device name
PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
Applicant location
Hackettstown, NJ
Received
Aug 9, 2013
Decided
Feb 4, 2014
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080012

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ADDITION OF A CATHETER REVISION KIT FOR USE WITH THE SUBJECT SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME PROMETRA PROGRAMMABLE IMPLANTABLE PUMP SYSTEM AND IS INDICATED FOR INTRATHECAL INFUSION OF INFUMORPH (PRESERVATIVE-FREE MORPHINE SULFATE) OR PRESERVATIVE-FREE STERILE 0.9% SALINE SOLUTION (SODIUM CHLORIDE INJECTION, USP).

Source documents

Other decisions for Infusyn Therapeutics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.